Allurion receives NYSE notice for market cap non-compliance; stock to trade with ".BC"

ALLURION TECHNOLOGIES, INC.

NYSE notified Allurion avg market cap <$50M over 30 days ended Aug 29, 2024 and equity <$50M.
Company has 45 days to submit a cure plan; if accepted, an 18-month cure period applies.
Common stock continues trading with ".BC" designation; no immediate delisting.
Allurion also previously received notice on Aug 12, 2024 for non-compliance with minimum closing price.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.